ImmunityBio (IBRX) investor relations material

Opening remarks and agenda

• The meeting was held virtually for the seventh consecutive year, allowing real-time online voting until polls closed.

• Directors, officers, the independent auditor, and legal counsel were present virtually.

• The meeting followed company bylaws and Delaware law, with notice and proxy materials distributed to stockholders.

Board and executive committee updates

• Nine incumbent directors were nominated for re-election to serve until the 2027 annual meeting.

• No stockholder nominations for director were received in advance.

Shareholder proposals

• The agenda included the election of directors and ratification of the independent auditor.